Prevention of infarct expansion

US2016287632A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016287632-A1
Application numberUS-201514962889-A
CountryUS
Kind codeA1
Filing dateDec 8, 2015
Priority dateSep 21, 2007
Publication dateOct 6, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are methods and kits for safe and effective therapy that can be administered early after a heart attack in order to prevent progressive heart dilatation and resultant loss of function. The therapy includes the administration of particulate compositions to a region comprising an infarct or a portion thereof.

First claim

Opening claim text (preview).

1 .- 16 . (canceled) 17 . A kit for use in the stabilization of cardiac infarct tissue comprising: a composition comprising a biologically compatible, acellular material comprising particles having characteristic dimensions of 25 μm to about 50 μm; and, an injection tool capable of delivering said composition directly into a cardiac infarct itself, and optionally into a region of tissue containing the infarct, into tissue adjacent to or partially or completely surrounding the infarct, or both within a living patient. 18 . The kit according to claim 17 wherein said material comprises microparticles of one or more forms of calcium phosphate. 19 . The kit according to claim 17 wherein said composition comprises a suspension of said microparticles in an aqueous carrier. 20 . The kit according to claim 17 wherein said injection tool comprises a catheter. 21 . The kit according to claim 17 wherein said composition is provided in one or more premeasured aliquots. 22 .- 25 . (canceled)

Assignees

Inventors

Classifications

  • for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

  • Flowable or injectable implant compositions · CPC title

  • Phosphorus-containing materials, e.g. apatite · CPC title

  • Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title

  • Ceramics or glasses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016287632A1 cover?
Provided are methods and kits for safe and effective therapy that can be administered early after a heart attack in order to prevent progressive heart dilatation and resultant loss of function. The therapy includes the administration of particulate compositions to a region comprising an infarct or a portion thereof.
Who is the assignee on this patent?
Univ Pennsylvania
What technology area does this patent fall under?
Primary CPC classification A61K33/42. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Oct 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).